secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2026-11-10T22:03:14+00:00
Accession:  0001520138-26-000471
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

BioVie holders approve 7.8x increase in 2019 equity plan share reserve at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amending the 2019 Omnibus Equity Incentive Plan to raise shares available for issuance from 399,509 to 3,100,000, roughly a 7.8x increase.
- The plan amendment drew the heaviest opposition: 1,020,704 for, 689,489 against, 136,939 abstained, with 2,902,235 broker non-votes.
- All six director nominees elected, including Amy Chappell (1,732,353 for / 114,779 withheld), Cuong Do, Kameel Farag, James Lang, Sigmund Rogich and Michael Sherman.
- EisnerAmper LLP ratified as independent auditor for fiscal year ending June 30, 2027 (4,411,653 for, 274,205 against, 63,509 abstain).
- Quorum met with 4,749,367 of 8,682,710 Class A shares outstanding on the Sept 21, 2026 record date present by proxy or virtually.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000471/0001520138-26-000471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000471/bivi-20261110_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-26-000471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer